The company creates Wireless Assessment of Respiratory and circulatory Distress (WARD), an AI-based solution for monitoring patients and their vital signs (heart/lung functions) and reducing the risk of complications through machine learning algorithms in a Clinical Support System (CSS).
Ward 24/7 has raised €3.4M across 1 funding round from 4 investors, most recently a round in Jan 2024. Based in Copenhagen, Denmark; active in AI. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-01-19 | Other | €3.4M |
| Danish business angels,Export and Investment Fund of Denmark (EIFO),Innovestor,Sagitta Ventures |
| View deal → |
